Bio-Rad Laboratories (BIO-B) Interest Coverage Ratio Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.47% |
| Dec 31, 2025 | -17.60% |
| Sep 30, 2025 | -22.62% |
| Jun 30, 2025 | -7.46% |
| Mar 31, 2025 | -31.47% |
| Dec 31, 2024 | -13.32% |
| Sep 30, 2024 | -12.51% |
| Jun 30, 2024 | -3.09% |
| Mar 31, 2024 | -17.45% |
| Dec 31, 2023 | 17.18% |
| Sep 30, 2023 | 4.16% |
| Jun 30, 2023 | -0.18% |
| Mar 31, 2023 | -7.84% |
| Dec 31, 2022 | 5.07% |
| Sep 30, 2022 | 4.22% |
| Jun 30, 2022 | 111.92% |
| Mar 31, 2022 | 48.97% |
| Dec 31, 2021 | 138.42% |
| Sep 30, 2021 | 146.69% |
| Jun 30, 2021 | 135.20% |
| Mar 31, 2021 | 133.90% |
| Dec 31, 2020 | 31.97% |
| Sep 30, 2020 | 27.80% |
| Jun 30, 2020 | 1.62% |
| Mar 31, 2020 | 13.74% |
| Dec 31, 2019 | -0.71% |
| Sep 30, 2019 | 19.26% |
| Jun 30, 2019 | 3.29% |
| Mar 31, 2019 | 12.25% |
| Dec 31, 2018 | -47.42% |
| Sep 30, 2018 | 45.44% |
| Jun 30, 2018 | 10.06% |
| Mar 31, 2018 | 18.71% |
| Dec 31, 2017 | 10.00% |
| Sep 30, 2017 | 3.60% |
| Jun 30, 2017 | -15.41% |
| Mar 31, 2017 | 3.66% |
| Dec 31, 2016 | -20.48% |
| Sep 30, 2016 | -7.62% |
| Jun 30, 2016 | -3.35% |
| Mar 31, 2016 | -1.99% |
| Dec 31, 2015 | 21.10% |
| Sep 30, 2015 | 1.56% |
| Jun 30, 2015 | 11.81% |
| Mar 31, 2015 | 9.42% |
| Dec 31, 2014 | 20.88% |
| Sep 30, 2014 | -1.50% |
| Jun 30, 2014 | 8.78% |